Connection

MARGARET GOODELL to Histone-Lysine N-Methyltransferase

This is a "connection" page, showing publications MARGARET GOODELL has written about Histone-Lysine N-Methyltransferase.
  1. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood. 2016 08 18; 128(7):971-81.
    View in: PubMed
    Score: 0.123
  2. It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice. Cancer Cell. 2020 03 16; 37(3):267-269.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.